Could a website help cancer patients avoid unwanted aggressive treatments?

NCT ID NCT07712237

Completed Symptom relief Sponsor: Tri-Service General Hospital (TSGH) Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This trial tests whether a web-based educational program can help people with advanced cancer reduce their preference for aggressive life-sustaining treatments. Participants are randomly assigned to receive either the web program plus an informational leaflet, or the leaflet alone. The study measures changes in treatment preferences through questionnaires at the start, right after the program, and one week later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a web-based advance care planning educational program
What this could lead to: If effective, this web-based tool could help patients with advanced cancer make more informed decisions about their end-of-life care and reduce unwanted aggressive treatments.
What could go wrong: This is a small, early-stage trial with only 110 participants and a short follow-up of one week, so results may not apply broadly. The intervention relies on internet access, which may limit its reach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED CANCER

Contacts and locations

Show contact details

Locations

Tri-Service General Hospital

Taipei, Taipei City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.